Norway· NO-ID_20ED0D19-1A93-443D-94DC-71E3F698264D

Teveten

A eprosartan product containing eprosartan mesilate, registered in Norway by 2care4 ApS. The same ATC class is registered in 8 of our 19 countries.

ATC C09CA02

Checked against FEST (Norway) on

Informational only — not a medical device.

SOURCE REGISTER · NOFEST (Norway)normalisedTevetenATCC09CA02REGISTER NO.NO-ID_20ED0D19-1A93-4…PACKS LISTED3CHECKEDSeptember 25, 2026

Where it is registered

Eprosartan is registered in 8 of 19 countries.

Countries holding a registration under ATC C09CA02 (eprosartan), each read from that country’s own register.

  • This record: Norway, from FEST (Norway)
  • 4 of them publish a price we can compare per daily dose

Eprosartan · ATC C09CA02

8 / 19 countries

  • Belgiumprice
  • Finlandprice
  • Germany
  • Ireland
  • Netherlands
  • Norwayprice
  • Spainprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of eprosartan costs, country by country.

Normalised to the WHO defined daily dose (0.6 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Eprosartan · price per daily dose (0.6 g)

USD · FX 28 Sept 2026

  • ES Spain$0.58
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FEST (Norway)
Active substance
Eprosartan Mesilate
Manufacturer
2care4 ApS
Country
Norway (NO)
ATC code
C09CA02
ATC class
Eprosartan
Defined daily dose
0.6 g, O
Reimbursed
Not published by this register
Source register
FEST (Norway)
Last checked
September 25, 2026

Packs & prices · 3

1 priced
  • no_merkevare_id
    ID_20ED0D19-1A93-443D-94DC-71E3F698264D
  • no_varenummer
    109530
    98
    NOK 603
  • gtin
    7046261095303

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

201 interactions on record for eprosartan.

Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Eprosartan · interactions on record

201 records

  • 7 severe
  • 113 moderate

Most severe, free to view

  • Potassium chlorideA12BA01severe
  • Potassium citrateA12BA02severe
  • Potassium gluconateA12BA05severe
  • Potassium chlorideB05XA01severe

81 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Eprosartan in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All eprosartan products

Authorised across Europe · EMA

The same active substance is authorised in 12 EEA countries. Names it is sold under:

  • Austria · Teveten
  • Belgium · Teveten
  • Bulgaria · Теветен
  • Germany · Eprosartan Amarox, Eprosartan Ratiopharm
  • Spain · Futuran, Navixen
  • Finland · Teveten
  • United Kingdom (Northern Ireland) · Eprosartan Activase Pharmaceuticals, Eprosartan Amarox
  • Greece · Teveten
  • Ireland · Teveten
  • Luxembourg · Teveten
  • Netherlands · Teveten
  • Portugal · Teveten

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d2de3e5f-68d8-4686-a727-542d43db6b11
GET /v1/drugs/d2de3e5f-68d8-4686-a727-542d43db6b11?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablett, filmdrasjert",
  "source": "fest",
  "status": "A",
  "atc_name": "Eprosartan",
  "merkevare_id": "ID_20ED0D19-1A93-443D-94DC-71E3F698264D",
  "name_form_strength": "Teveten tab 600 mg",
  "prescription_group": "C"
}

See everything about eprosartan.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.